86 results
DEFR14A
ACET
Adicet Bio Inc
26 Apr 24
Revised proxy
4:13pm
be independent of Company management and performs an annual assessment of the compensation consultants’ independence to determine whether the consultants … if such reduction would result in a higher net after-tax benefit to Dr. Healey.
Compensation Risk Assessment
We believe that although a portion
PRE 14A
ACET
Adicet Bio Inc
12 Apr 24
Preliminary proxy
5:23pm
be independent of Company management and performs an annual assessment of the compensation consultants’ independence to determine whether the consultants … if such reduction would result in a higher net after-tax benefit to Dr. Healey.
Compensation Risk Assessment
We believe that although a portion
8-K
EX-1.1
ACET
Adicet Bio Inc
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
as would not reasonably be expected to result in a Material Adverse Effect, no deficiency assessment with respect to a proposed adjustment of the Company’s
8-K
EX-1.1
vbfkcx usl564w50dms
24 Jan 24
Adicet Bio, Inc. Announces Proposed Public Offering
4:34pm
8-K
EX-99.1
k2hb7
16 Jan 24
Regulation FD Disclosure
7:01am
8-K
fz3d3av
26 Jun 23
Regulation FD Disclosure
4:02pm
8-K
EX-99.1
11rn5u x9mfpz9xn
26 Jun 23
Regulation FD Disclosure
4:02pm
8-K
EX-99.1
f9xpt6jezfwkylh
12 Dec 22
Regulation FD Disclosure
6:03am
8-K
qwstta5uvg0
12 Dec 22
Regulation FD Disclosure
6:03am
8-K
EX-99.1
ndmq6g1i tu3
10 Nov 22
Regulation FD Disclosure
5:09pm
8-K
EX-99.1
ivgf53t8
6 Jun 22
Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
4:01pm